Multi-scale discriminative regions analysis in FDG-PET imaging for early diagnosis of Alzheimer's disease

被引:5
|
作者
Zhang, Jin [1 ]
He, Xiaohai [1 ]
Qing, Linbo [1 ]
Xu, Yining [1 ]
Liu, Yan [2 ]
Chen, Honggang [1 ]
机构
[1] Sichuan Univ, Coll Elect & Informat Engn, Chengdu 610065, Sichuan, Peoples R China
[2] Southwest Jiaotong Univ, Peoples Hosp Chengdu 3, Dept Neurol, Affiliated Hosp, Chengdu 610014, Sichuan, Peoples R China
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; fluorodeoxyglucose positron emission tomography; artificial intelligence; medical image processing; mild cognitive impairment; BRAIN IMAGES; CLASSIFICATION; MCI; CONVERSION; NETWORK; AD;
D O I
10.1088/1741-2552/ac8450
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective. Alzheimer's disease (AD) is a degenerative brain disorder, one of the main causes of death in elderly people, so early diagnosis of AD is vital to prompt access to medication and medical care. Fluorodeoxyglucose positron emission tomography (FDG-PET) proves to be effective to help understand neurological changes via measuring glucose uptake. Our aim is to explore information-rich regions of FDG-PET imaging, which enhance the accuracy and interpretability of AD-related diagnosis. Approach. We develop a novel method for early diagnosis of AD based on multi-scale discriminative regions in FDG-PET imaging, which considers the diagnosis interpretability. Specifically, a multi-scale region localization module is discussed to automatically identify disease-related discriminative regions in full-volume FDG-PET images in an unsupervised manner, upon which a confidence score is designed to evaluate the prioritization of regions according to the density distribution of anomalies. Then, the proposed multi-scale region classification module adaptively fuses multi-scale region representations and makes decision fusion, which not only reduces useless information but also offers complementary information. Most of previous methods concentrate on discriminating AD from cognitively normal (CN), while mild cognitive impairment, a transitional state, facilitates early diagnosis. Therefore, our method is further applied to multiple AD-related diagnosis tasks, not limited to AD vs. CN. Main results. Experimental results on the Alzheimer's Disease Neuroimaging Initiative dataset show that the proposed method achieves superior performance over state-of-the-art FDG-PET-based approaches. Besides, some cerebral cortices highlighted by extracted regions cohere with medical research, further demonstrating the superiority. Significance. This work offers an effective method to achieve AD diagnosis and detect disease-affected regions in FDG-PET imaging. Our results could be beneficial for providing an additional opinion on the clinical diagnosis.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] FDG-PET for early assessment of Alzheimer's disease: isn't the evidence base large enough?
    Lucignani, Giovanni
    Nobili, Flavio
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (08) : 1604 - 1609
  • [42] Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease
    Kudo, Yukitsuka
    MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2006, 15 (04) : 209 - 213
  • [43] Spatial covariance analysis of FDG-PET and HMPAO-SPECT for the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease
    Ingram, Matthew
    Colloby, Sean J.
    Firbank, Michael J.
    Lloyd, Jim J.
    O'Brien, John T.
    Taylor, John-Paul
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2022, 322
  • [44] Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease
    Dukart, Juergen
    Kherif, Ferath
    Mueller, Karsten
    Adaszewski, Stanislaw
    Schroeter, Matthias L.
    Frackowiak, Richard S. J.
    Draganski, Bogdan
    PLOS COMPUTATIONAL BIOLOGY, 2013, 9 (04)
  • [45] Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study
    Delrieu, Julien
    Desmidt, Thomas
    Camus, Vincent
    Sourdet, Sandrine
    Boutoleau-Bretonniere, Claire
    Mullin, Emmanuel
    Vellas, Bruno
    Payoux, Pierre
    Lebouvier, Thibaud
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (05) : 470 - 477
  • [46] Mapping biochemistry to metabolism: FDG-PET and amyloid burden in Alzheimer's disease
    Mega, MS
    Chu, T
    Mazziotta, JC
    Trivedi, KH
    Thompson, PM
    Shah, A
    Cole, G
    Frautschy, SA
    Toga, AW
    NEUROREPORT, 1999, 10 (14) : 2911 - 2917
  • [47] Neural Correlates of Stroop Performance in Alzheimer's Disease: A FDG-PET Study
    Yun, Je-Yeon
    Lee, Dong Young
    Seo, Eun Hyun
    Choo, Il Han
    Park, Shin Young
    Kim, Shin Gyeom
    Woo, Jong In
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 190 - 201
  • [48] Therapy control of cholinesterase inhibitors in Alzheimer's disease using FDG-PET
    Kratzsch, T
    Kramer, J
    Peters, J
    Frölich, L
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S369 - S369
  • [49] Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study
    Mosconi, L
    Sorbi, S
    Nacmias, B
    De Cristofaro, MTR
    Fayyaz, M
    Bracco, L
    Herholz, K
    Pupi, A
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2004, 130 (02) : 141 - 151
  • [50] FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
    Foster, Norman L.
    Heidebrink, Judith L.
    Clark, Christopher M.
    Jagust, William J.
    Arnold, Steven E.
    Barbas, Nancy R.
    DeCarli, Charles S.
    Turner, R. Scott
    Koeppe, Robert A.
    Higdon, Roger
    Minoshima, Satoshi
    BRAIN, 2007, 130 : 2616 - 2635